Abstract
During the past 12 years, among 1478 operations for non-small-cell lung cancer (NSCLC), 102 (6.9%) bronchosplastic resections were performed. There were 74 lobectomies, 19 bilobectomies, and 9 pneumonectomies done by means of 72 sleeve-, 28 wedge resections, and 2 resections of the tracheal bifurcation. Atelectasis was observed in 6%, whereas anastomotic dehiscence occurred in 4%. Local complete resection was achieved in 81%. The 30-day mortality amounted to 4%. Our results demonstrate that bronchoplastic procedures represent a safe therapeutic option in the operative treatment of central NSCLC.
| Original language | English |
|---|---|
| Pages (from-to) | 248-251 |
| Number of pages | 4 |
| Journal | Thoracic and Cardiovascular Surgeon |
| Volume | 44 |
| Issue number | 5 |
| DOIs | |
| State | Published - Oct 1996 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- NSCLC
- bronchoplastic resection
Fingerprint
Dive into the research topics of 'Bronchoplastic resection for non-small-cell lung cancer'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver